Allergies News and Research

Latest Allergies News and Research

Popular Science magazine names University of Minnesota chemist among ‘Brilliant 10’

University of Minnesota chemist Christy Haynes has been named one of Popular Science magazine's "Brilliant 10," an honor that recognizes an elite group of young scientists whose research is expected to dramatically impact their fields. Haynes' profile was published today on the PopSci website and is featured in the Popular Science magazine now on newsstands.

12 Sep 2012

Researchers present new results from RV144 HIV vaccine trial at AIDS Vaccine 2012

"A paper published in Nature on Monday sheds light on how a vaccine can turn the immune system against [HIV] and so offer protection from infection," Nature News reports, noting "[t]he results are also being presented at the AIDS Vaccine 2012 conference in Boston, Massachusetts, this week."

12 Sep 2012

KaloBios commences KB003 Phase 2 trial in severe asthma

KaloBios Pharmaceuticals, Inc. today announced that dosing has begun in a randomized, double-blind, placebo-controlled Phase 2 clinical trial of KB003, the company's anti-GM-CSF Humaneered monoclonal antibody, in subjects with severe asthma uncontrolled by corticosteroids.

12 Sep 2012

BRI scientists receive two major grant awards for research into autoimmunity prevention

Benaroya Research Institute at Virginia Mason (BRI) recently received two major grant awards to explore how to regulate the immune system, as part of a nationwide collaborative program to prevent autoimmune diseases.

11 Sep 2012

Strep throat should be treated with penicillin or amoxicillin: IDSA guidelines

Although people often say they have "strep" throat, most sore throats actually are caused by a virus, not streptococcus bacteria, and shouldn't be treated with antibiotics, suggest guidelines published by the Infectious Diseases Society of America (IDSA). Antibiotics are ineffective against viruses.

11 Sep 2012

Researchers discover small DNA sequence that drives GATA2 protein

The protein GATA2 is known as a "master regulator" of blood cell development. When a mutation occurs in the gene that makes GATA2, serious blood diseases such as acute myeloid leukemia can result.

11 Sep 2012

HIV viruses with two genetic 'footprints' associated with greater vaccine efficacy

Scientists used genetic sequencing to discover new evidence that the first vaccine shown to prevent HIV infection in people also affected the viruses in those who did become infected. Viruses with two genetic "footprints" were associated with greater vaccine efficacy. The results were published today in the online edition of the journal Nature.

10 Sep 2012

Researchers, policymakers to gather at AIDS Vaccine 2012 conference in Boston

"With a completed trial in Thailand that offered evidence a vaccine could be developed to protect people from HIV, emerging science identifying antibodies against HIV, and a current trial testing a novel vaccine combination against the virus potentially producing more information in the next year, this is an exciting time to hold a conference, organizers of AIDS Vaccine 2012 say," the Center for Global Health Policy's "Science Speaks" blog reports.

7 Sep 2012

Outbreak of autoimmune disease with AIDS-like symptoms in Southeast Asia

There has been an outbreak of an adult-onset immunodeficiency syndrome in Southeast Asia. The autoimmune disease causes AIDS-like symptoms but is not associated with HIV and is not contagious.

7 Sep 2012

Biopsies may misdiagnose eosinophilic esophagitis

University of Utah engineers mapped white blood cells called eonsinophils and showed an existing diagnostic method may overlook an elusive digestive disorder that causes swelling in the esophagus and painful swallowing.

7 Sep 2012

Hebrew University researcher develops anti-inflammatory and anti-allergic family of drugs

A synthetic, anti-inflammatory and anti-allergic family of drugs to combat a variety of illnesses while avoiding detrimental side effects has been developed by a Hebrew University of Jerusalem researcher.

7 Sep 2012

Midwest pollen count hits new high

The Midwest's pollen count today hit a new high for the season. "Mold, weeds and ragweed are all high and also grass is high, which may surprise many people. The grass is corn grass and the high levels are caused by the seasonal harvesting of the corn as corn is a member of the botanical grass family," said Dr. Joseph Leija, who performs the Gottlieb Allergy Count, the official allergy count for the Midwest.

7 Sep 2012

Antibiotics: facts and fictions: an interview with Dr Philippa Binns, clinical adviser at NPS MedicineWise

Antibiotics are medicines used to treat infections or diseases caused by bacteria, such as some respiratory tract infections (including pneumonia and whooping cough), urinary tract infections, skin infections and infected wounds.

6 Sep 2012

Rigel commences R343 and R333 Phase 2 studies in allergic asthma, discoid lupus erythematosus

Rigel Pharmaceuticals, Inc. today announced that it has commenced Phase 2 clinical studies with two of the company's most advanced proprietary therapeutic product candidates. R343 is an inhaled SYK inhibitor that is being evaluated as a potential treatment for allergic asthma.

6 Sep 2012

On-the-spot test aids postsurgical coagulopathy management

Point-of-care thromboelastometric and aggregometric testing helps to reduce exposure to allogenic blood products in patients with coagulopathy after cardiac surgery, a randomized trial shows.

5 Sep 2012

CT scan appears to predict risk of chronic obstructive pulmonary disease exacerbations

The respective size of two major arteries, visible on a simple computed tomography, or CT, scan, is a strong predictor of the risk of exacerbation of chronic obstructive pulmonary disease, according to new research from the University of Alabama at Birmingham published online Sept. 3, 2012, in the New England Journal of Medicine.

3 Sep 2012

Potential new COPD drug

A study led by researchers at Boston University School of Medicine (BUSM) has shown that a compound used in some skin creams may halt the progression of emphysema and reverse some of the damage caused by the disease. When the compound Gly-His-Lys (GHK) was applied to lung cells from patients with emphysema, normal gene activity in altered cells was restored and damaged aspects of cellular function were repaired.

1 Sep 2012

Exposure to polychlorinated biphenyls could increase risk of asthma symptoms in children

Children who are exposed to polychlorinated biphenyls (PCBs), which were commonly used in a range of industrial products, could be at risk of an increase in asthma symptoms, according to new research.

1 Sep 2012

University of Leicester scientists secure funding for Exhalyzer-D to help children's breathing

University of Leicester medical scientists have secured funding for a piece of state-of-the-art equipment to help with their research into children's breathing.

1 Sep 2012

Researchers define new treatment for potentially fatal lung disease in patients with CVID

A team of researchers at the Medical College of Wisconsin and Children's Hospital of Wisconsin Research Institute defined a new treatment for a potentially fatal lung disease in patients with a primary immunodeficiency known as common variable immunodeficiency (CVID).

1 Sep 2012

Allergies News and Research

Latest Allergies News and Research

Popular Science magazine names University of Minnesota chemist among ‘Brilliant 10’

Researchers present new results from RV144 HIV vaccine trial at AIDS Vaccine 2012

KaloBios commences KB003 Phase 2 trial in severe asthma

BRI scientists receive two major grant awards for research into autoimmunity prevention

Strep throat should be treated with penicillin or amoxicillin: IDSA guidelines

Researchers discover small DNA sequence that drives GATA2 protein

HIV viruses with two genetic 'footprints' associated with greater vaccine efficacy

Researchers, policymakers to gather at AIDS Vaccine 2012 conference in Boston

Outbreak of autoimmune disease with AIDS-like symptoms in Southeast Asia

Biopsies may misdiagnose eosinophilic esophagitis

Hebrew University researcher develops anti-inflammatory and anti-allergic family of drugs

Midwest pollen count hits new high

Antibiotics: facts and fictions: an interview with Dr Philippa Binns, clinical adviser at NPS MedicineWise

Rigel commences R343 and R333 Phase 2 studies in allergic asthma, discoid lupus erythematosus

On-the-spot test aids postsurgical coagulopathy management

CT scan appears to predict risk of chronic obstructive pulmonary disease exacerbations

Potential new COPD drug

Exposure to polychlorinated biphenyls could increase risk of asthma symptoms in children

University of Leicester scientists secure funding for Exhalyzer-D to help children's breathing

Researchers define new treatment for potentially fatal lung disease in patients with CVID

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Allergies News and Research

Latest Allergies News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in